<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39311127</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2226-4787</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Pharmacy (Basel, Switzerland)</Title><ISOAbbreviation>Pharmacy (Basel)</ISOAbbreviation></Journal><ArticleTitle>Drug Shortage and Ethical Issues: Integrating Multidisciplinary Perspectives with a Shared Ethical Framework.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmacy12050136</ELocationID><Abstract><AbstractText>Drug shortages can cause ethical dilemmas when no systematic, equitable allocation, or utilization schema is in place. During the COVID-19 pandemic, an ethical framework outlining moral values was proposed as way to approach allocating limited resources to patients. In addition to an ethical perspective, it is prudent to consider costs. Examining existing economic frameworks and combining them with an ethical perspective may provide a practical, systematic process for decision makers when allocating drugs in short supply. Drug shortages continue to impact multiple areas across different subspecialties of medicine due to multiple factors, including limited manufacturers, regulatory issues, and costs. All of these factors make it difficult to anticipate and manage drug shortages effectively, but developing a combined framework may reduce some of the ethical and equitable ambiguity with regards to patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wai</LastName><ForeName>Maya C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Department of Pharmacy Practice, Northwest Regional Campus, University of Arkansas for Medical Sciences, 1125 N. College Ave., Fayetteville, AR 72703, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmacy (Basel)</MedlineTA><NlmUniqueID>101678532</NlmUniqueID><ISSNLinking>2226-4787</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">drug shortages</Keyword><Keyword MajorTopicYN="N">economics</Keyword><Keyword MajorTopicYN="N">ethics</Keyword><Keyword MajorTopicYN="N">multidisciplinary</Keyword></KeywordList><CoiStatement>The author declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311127</ArticleId><ArticleId IdType="pmc">PMC11417769</ArticleId><ArticleId IdType="doi">10.3390/pharmacy12050136</ArticleId><ArticleId IdType="pii">pharmacy12050136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shukar S., Zahoor F., Hayat K., Saeed A., Gillani A.H., Omer S., Hu S., Babar Z., Fang Y., Yang C. Drug shortage: Causes, impact, and mitigation strategies. Front. Pharmacol. 2021;12:693426. doi: 10.3389/fphar.2021.693426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.693426</ArticleId><ArticleId IdType="pmc">PMC8299364</ArticleId><ArticleId IdType="pubmed">34305603</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of the Secretary  . Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States. Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services; Washington, DC, USA: 2024.  [(accessed on 20 June 2024)].  Available online:  https://aspe.hhs.gov/reports/preventing-shortages-supply-chain-vulnerabilities.</Citation></Reference><Reference><Citation>ASHP  . Policy Solutions to Address the Drug Shortage Crisis. American Society of Health-System Pharmacists; Bethesda, MD, USA: 2023.  [(accessed on 20 June 2024)].  Available online:  https://www.ashp.org/-/media/assets/advocacy-issues/docs/2023/ASHP-Drug-Shortage-Recommendations.pdf.</Citation></Reference><Reference><Citation>Walsh J.D. The Empty Adderall Factory. New York Magazine. Feb 19, 2024.  [(accessed on 20 June 2024)].  Available online:  https://nymag.com/intelligencer/article/adderall-shortage-adhd-medication-ascent-pharmaceuticals.html.</Citation></Reference><Reference><Citation>Tucker E.L., Cao Y., Fox E.R., Sweet B.V. The drug shortage era: A scoping review of the literature 2001–2019. Clin. Pharmacol. Ther. 2020;108:1150–1155. doi: 10.1002/cpt.1934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1934</ArticleId><ArticleId IdType="pubmed">32521038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.N. Iatrogenic malnutrition: A serious public health issue caused by drug shortages. J. Parenter. Enteral. Nutr. 2013;37:702–704. doi: 10.1177/0148607113509282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607113509282</ArticleId><ArticleId IdType="pubmed">24186877</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzger M.L., Billett A., Link M.P. The impact of drug shortages on children with cancer—The example of Mechlorethamine. N. Engl. J. Med. 2012;367:2461–2463. doi: 10.1056/NEJMp1212468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1212468</ArticleId><ArticleId IdType="pubmed">23268661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hick J.L., Hanfling D., Courtney B., Lurie N. Rationing salt water—Disaster planning and daily care delivery. N. Engl. J. Med. 2014;370:1573–1576. doi: 10.1056/NEJMp1401833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1401833</ArticleId><ArticleId IdType="pubmed">24645847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazer-Amirshahi M., Fox E.R. Saline shortages—Many causes, no simple solution. N. Engl. J. Med. 2018;378:1472–1474. doi: 10.1056/NEJMp1800347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1800347</ArticleId><ArticleId IdType="pubmed">29561694</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralls M.W., Blackwood A., Arnold M.A., Partipilo M.L., Dimond J., Teitelbaum D.H. Drug shortage—Associated increase in catheter-related blood stream infection in children. Pediatrics. 2012;130:e1369–e1373. doi: 10.1542/peds.2011-3894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-3894</ArticleId><ArticleId IdType="pubmed">23045557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlotter M., Schwerdt G., Woessmann L. Econometric methods for causal evaluation of education policies and practices: A non-technical guide. Educ. Econ. 2011;19:109–137. doi: 10.1080/09645292.2010.511821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09645292.2010.511821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosinska M.  Drug Shortages: A Guide to Policy Solutions. Brookings Institution; Washington, DC, USA: 2024.  [(accessed on 20 June 2024)].  Available online:  https://www.brookings.edu/articles/drug-shortages-a-guide-to-policy-solutions/</Citation></Reference><Reference><Citation>ASHP  . Severity and Impact of Current Drug Shortages. American Society of Health-System Pharmacists; Bethesda, MD, USA: 2023.  [(accessed on 20 June 2024)].  Available online:  https://www.ashp.org/-/media/assets/drug-shortages/docs/ASHP-2023-Drug-Shortages-Survey-Report.pdf.</Citation></Reference><Reference><Citation>Hantel A., Spence R., Camacho P., Bradbury A.R., Denburg A.E., Jagsi R., Moy B., Rathmell W.K., Rosenberg A.R., Symington B., et al. ASCO ethical guidance for the practical management of oncology drug shortages. J. Clin. Oncol. 2023;42:358–365. doi: 10.1200/JCO.23.01941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.23.01941</ArticleId><ArticleId IdType="pubmed">38061010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipworth W., Kerridge I. Why drug shortages are an ethical issue. Australas. Med. J. 2013;6:556–559. doi: 10.4066/AMJ.2013.1869.</Citation><ArticleIdList><ArticleId IdType="doi">10.4066/AMJ.2013.1869</ArticleId><ArticleId IdType="pmc">PMC3858608</ArticleId><ArticleId IdType="pubmed">24348871</ArticleId></ArticleIdList></Reference><Reference><Citation>Persad G., Wertheimer A., Emanuel E.J. Principles for allocation of scarce medical interventions. Lancet. 2009;373:423–431. doi: 10.1016/S0140-6736(09)60137-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60137-9</ArticleId><ArticleId IdType="pubmed">19186274</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuel E.J., Persad G. The shared ethical framework to allocate scarce medical resources: A lesson from COVID-19. Lancet. 2023;401:1892–1902. doi: 10.1016/S0140-6736(23)00812-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00812-7</ArticleId><ArticleId IdType="pmc">PMC10168660</ArticleId><ArticleId IdType="pubmed">37172603</ArticleId></ArticleIdList></Reference><Reference><Citation>The Covid Crisis Group . Lessons from the Covid War: An Investigative Report. Public Affairs; New York, NY, USA: 2023.</Citation></Reference><Reference><Citation>AMA. ASA. ASHP. ASCO. USP  . Improving the Quality and Resilience of the United States Healthcare Supply Chain. American Society of Health-System Pharmacists; Bethesda, MD, USA: 2021.  [(accessed on 20 June 2024)].  Available online:  https://www.ashp.org/-/media/assets/news-and-media/docs/Healthcare-Supply-Chain-Recommendations.</Citation></Reference><Reference><Citation>Woodcock J., Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin. Pharmacol. Ther. 2012;93:170–176. doi: 10.1038/clpt.2012.220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2012.220</ArticleId><ArticleId IdType="pubmed">23337525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez I., San-Juan-Rodriguez A., Good C.B., Gellad W.F. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007–2018. JAMA. 2020;323:854–862. doi: 10.1001/jama.2020.1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1012</ArticleId><ArticleId IdType="pmc">PMC7054846</ArticleId><ArticleId IdType="pubmed">32125403</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox E.R., McLaughlin M.M. ASHP guidelines on managing drug product shortages. Am. J. Health Syst. Pharm. 2018;75:1742–1750. doi: 10.2146/ajhp180441.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp180441</ArticleId><ArticleId IdType="pubmed">30061155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosoff P.M. Unpredictable drug shortages: An ethical framework for short-term rationing in hospitals. Am. J. Bioeth. 2012;12:1–9. doi: 10.1080/15265161.2011.634483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15265161.2011.634483</ArticleId><ArticleId IdType="pubmed">22220948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>